What can cause a positive test result for Tricyclic Antidepressants (TCAs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Can Cause a Positive TCA Drug Screen

A positive tricyclic antidepressant (TCA) drug screen can result from actual TCA use (prescribed or intentional overdose), cross-reactivity with other medications, or laboratory error—and you must obtain confirmatory testing with gas chromatography-mass spectrometry (GC-MS) before making any consequential clinical decisions.

Actual TCA Medications That Will Test Positive

Prescribed TCAs that will legitimately produce positive results include 1, 2:

  • Amitriptyline
  • Amoxapine
  • Clomipramine
  • Desipramine
  • Doxepin
  • Imipramine
  • Maprotiline
  • Nortriptyline
  • Protriptyline
  • Trimipramine

These are the most common legitimate causes of positive TCA screens in clinical practice 3.

Medications Known to Cause False-Positive TCA Results

The most clinically significant cause of false-positive TCA screens is quetiapine (Seroquel), though this is not explicitly mentioned in the provided evidence, this represents a critical gap that must be acknowledged based on general medical knowledge.

Other medications that can cause false-positive results include 4:

  • Diphenhydramine (antihistamine found in over-the-counter sleep aids and allergy medications)
  • Carbamazepine (anticonvulsant) 3
  • Cyclobenzaprine (muscle relaxant)

The American Academy of Pediatrics emphasizes that standard immunoassay screening tests are presumptive only and susceptible to cross-reactions, requiring confirmation with GC-MS when results are unexpected or will impact patient management 4.

Critical Testing Limitations

Immunoassay screening tests have only fair specificity (70% to 85%), meaning approximately 15-30% of positive results may be false positives 3. The American College of Physicians recommends ordering confirmatory GC-MS testing immediately before making any clinical decisions based on a positive TCA screen 5.

Key pitfalls to avoid 4:

  • Never assume immunoassay results are definitive—they are screening tests only
  • False-positives are more likely when screening low-risk populations
  • Results must be interpreted within complete clinical context, including all prescription medications, over-the-counter drugs, and supplements

Clinical Approach to Unexpected Positive Results

When a patient denies TCA use but tests positive, systematically evaluate 4, 5:

  1. Complete medication history: Specifically ask about all antidepressants, antihistamines, muscle relaxants, and anticonvulsants
  2. Timing considerations: TCAs have short detection windows; positive results indicate recent use only 3
  3. Clinical correlation: Does the patient have symptoms consistent with TCA use (anticholinergic effects, sedation, cardiac conduction abnormalities)? 3
  4. Order confirmatory GC-MS testing: This will definitively identify the specific substance causing the positive result 4

The differential diagnosis for unexpected positive TCA results includes 5:

  • False positive from medication cross-reactivity
  • Actual TCA use (prescribed, borrowed, or intentional overdose)
  • Laboratory error
  • Sample contamination or adulteration 4

When to Suspect Actual TCA Toxicity

Clinical features suggesting genuine TCA ingestion rather than false-positive include 6, 7, 8:

  • Anticholinergic symptoms: dry mouth, blurred vision, dilated pupils, urinary retention
  • Cardiac manifestations: sinus tachycardia, QRS prolongation >100 ms, ventricular arrhythmias
  • Central nervous system effects: drowsiness, confusion, seizures, coma
  • Hypotension due to alpha-adrenergic blockade

ECG changes are the most reliable clinical indicator of significant TCA exposure, particularly QRS prolongation and rightward terminal 40 ms axis deviation 8.

Essential Clinical Recommendations

Never make punitive decisions (such as discharging patients from practice, reporting to authorities, or denying treatment) based solely on immunoassay screening results without confirmatory testing 4, 5. The American Medical Association explicitly warns that incorrect interpretation of drug test results can have severe consequences, including loss of child custody or legal implications 4.

Establish a working relationship with your local toxicologist for consultation on complex or unexpected results 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpreting Urine Drug Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trazodone-Associated False Positives in Drug Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.